Europe Artificial Pancreas Devices System Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Artificial Pancreas Devices System Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Threshold Suspend Device System Market Performance (Volume)
  • 2.1.2 Non-Threshold Suspend Device System (NTSDS) Market Performance (Volume)
  • 2.1.3 Control To Range System (CTRS) Market Performance (Volume)
  • 2.1.4 Control To Target System (CTTS) Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Threshold Suspend Device System Market Performance (Value)
  • 2.1.2 Non-Threshold Suspend Device System (NTSDS) Market Performance (Value)
  • 2.1.3 Control To Range System (CTRS) Market Performance (Value)
  • 2.1.4 Control To Target System (CTTS) Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Hospital Market Performance (Volume)
  • 3.1.2 Clinic Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Medtronic
  • 4.1.1 Medtronic Profiles
  • 4.1.2 Medtronic Product Information
  • 4.1.3 Medtronic Artificial Pancreas Devices System Business Performance
  • 4.1.4 Medtronic Artificial Pancreas Devices System Business Development and Market Status
• 4.2 Johnson & Johnson
  • 4.2.1 Johnson & Johnson Profiles
  • 4.2.2 Johnson & Johnson Product Information
  • 4.2.3 Johnson & Johnson Artificial Pancreas Devices System Business Performance
  • 4.2.4 Johnson & Johnson Artificial Pancreas Devices System Business Development and Market Status
• 4.3 Insulet
  • 4.3.1 Insulet Profiles
  • 4.3.2 Insulet Product Information
  • 4.3.3 Insulet Artificial Pancreas Devices System Business Performance
  • 4.3.4 Insulet Artificial Pancreas Devices System Business Development and Market Status
• 4.4 Tandem Diabetes Care
  • 4.4.1 Tandem Diabetes Care Profiles
  • 4.4.2 Tandem Diabetes Care Product Information
  • 4.4.3 Tandem Diabetes Care Artificial Pancreas Devices System Business Performance
  • 4.4.4 Tandem Diabetes Care Artificial Pancreas Devices System Business Development and Market Status
• 4.5 Roche
  • 4.5.1 Roche Profiles
  • 4.5.2 Roche Product Information
  • 4.5.3 Roche Artificial Pancreas Devices System Business Performance
  • 4.5.4 Roche Artificial Pancreas Devices System Business Development and Market Status
• 4.6 Beta Bionics
  • 4.6.1 Beta Bionics Profiles
  • 4.6.2 Beta Bionics Product Information
  • 4.6.3 Beta Bionics Artificial Pancreas Devices System Business Performance
  • 4.6.4 Beta Bionics Artificial Pancreas Devices System Business Development and Market Status
• 4.7 Bigfoot Biomedical
  • 4.7.1 Bigfoot Biomedical Profiles
  • 4.7.2 Bigfoot Biomedical Product Information
  • 4.7.3 Bigfoot Biomedical Artificial Pancreas Devices System Business Performance
  • 4.7.4 Bigfoot Biomedical Artificial Pancreas Devices System Business Development and Market Status
• 4.8 Cellnovo
  • 4.8.1 Cellnovo Profiles
  • 4.8.2 Cellnovo Product Information
  • 4.8.3 Cellnovo Artificial Pancreas Devices System Business Performance
  • 4.8.4 Cellnovo Artificial Pancreas Devices System Business Development and Market Status
• 4.9 Dexcom
  • 4.9.1 Dexcom Profiles
  • 4.9.2 Dexcom Product Information
  • 4.9.3 Dexcom Artificial Pancreas Devices System Business Performance
  • 4.9.4 Dexcom Artificial Pancreas Devices System Business Development and Market Status
• 4.10 Dose Safety
  • 4.10.1 Dose Safety Profiles
  • 4.10.2 Dose Safety Product Information
  • 4.10.3 Dose Safety Artificial Pancreas Devices System Business Performance
  • 4.10.4 Dose Safety Artificial Pancreas Devices System Business Development and Market Status
• 4.11 DreaMed Diabetes
• 4.12 Inreda Diabetic
• 4.13 Insulet

5 Market Performance for Manufacturers

• 5.1 Europe Artificial Pancreas Devices System Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Europe Artificial Pancreas Devices System Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Europe Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Europe Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Germany Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Germany Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Germany Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 UK Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 UK Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 UK Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 France Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 France Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 France Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Russia Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Russia Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Russia Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Benelux Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Benelux Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Benelux Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Italy Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Italy Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Italy Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Spain Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Spain Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Spain Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Europe Artificial Pancreas Devices System Market Performance (Sales Point)

• 7.1 Europe Artificial Pancreas Devices System Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Europe Artificial Pancreas Devices System Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Europe Artificial Pancreas Devices System Price (USD/Unit) by Regions 2013-2018
• 7.4 Europe Artificial Pancreas Devices System Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Germany Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 UK Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 France Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Russia Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Benelux Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Italy Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Hospital Industry
• 11.2 Clinic Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Europe Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Europe Artificial Pancreas Devices System Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Germany Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 UK Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 France Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Russia Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Benelux Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Italy Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Spain Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Threshold Suspend Device System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Non-Threshold Suspend Device System (NTSDS) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Control To Range System (CTRS) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.5 Control To Target System (CTTS) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Hospital Sales and and Growth Rate 2019-2024
  • 12.4.3 Clinic Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Europe Artificial Pancreas Devices System Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Europe Artificial Pancreas Devices System Gross Profit Trend 2019-2024

13 Conclusion